Search
forResearch 10 of 1000+
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata
- Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris
- Contact immunotherapy‐resistant alopecia areata totalis/universalis reactive to topical corticosteroid
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Vitiliginous lesions during contact immunotherapy for alopecia in a patient with autoimmune thyroiditis
- Successful Treatment of Multiple Alopecia Areata With Contact Immunotherapy: Supportive Usage of Oral Antihistamine and Topical Corticosteroid
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low‐level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow‐up based on clinical studies
Community 1 of 21
All community results →Learn
— no results
Try a deeper search in learn →